vs
Side-by-side financial comparison of Insight Molecular Diagnostics Inc. (IMDX) and INTRUSION INC (INTZ). Click either name above to swap in a different company.
INTRUSION INC is the larger business by last-quarter revenue ($1.5M vs $1.1M, roughly 1.3× Insight Molecular Diagnostics Inc.). INTRUSION INC runs the higher net margin — -190.7% vs -2015.4%, a 1824.6% gap on every dollar of revenue. On growth, INTRUSION INC posted the faster year-over-year revenue change (-11.6% vs -23.4%). INTRUSION INC produced more free cash flow last quarter ($-549.0K vs $-7.0M). Over the past eight quarters, Insight Molecular Diagnostics Inc.'s revenue compounded faster (154.4% CAGR vs 14.4%).
Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
INTRUSION INCINTZEarnings & Financial Report
Intrusion Inc. is a cybersecurity company based in Plano, Texas. It provides cybersecurity solutions, including network intrusion detection and prevention systems.
IMDX vs INTZ — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1M | $1.5M |
| Net Profit | $-23.0M | $-2.8M |
| Gross Margin | 42.5% | 74.3% |
| Operating Margin | -2057.5% | -192.4% |
| Net Margin | -2015.4% | -190.7% |
| Revenue YoY | -23.4% | -11.6% |
| Net Profit YoY | 31.5% | -44.4% |
| EPS (diluted) | $-0.75 | $-0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1M | $1.5M | ||
| Q3 25 | $260.0K | $2.0M | ||
| Q2 25 | $518.0K | $1.9M | ||
| Q1 25 | $2.1M | $1.8M | ||
| Q4 24 | $1.5M | $1.7M | ||
| Q3 24 | $115.0K | $1.5M | ||
| Q2 24 | $104.0K | $1.5M | ||
| Q1 24 | $176.0K | $1.1M |
| Q4 25 | $-23.0M | $-2.8M | ||
| Q3 25 | $-10.9M | $-2.1M | ||
| Q2 25 | $-9.7M | $-2.0M | ||
| Q1 25 | $-6.7M | $-2.1M | ||
| Q4 24 | $-33.5M | $-2.0M | ||
| Q3 24 | $-13.5M | $-2.0M | ||
| Q2 24 | $-4.5M | $-2.1M | ||
| Q1 24 | $-9.1M | $-1.7M |
| Q4 25 | 42.5% | 74.3% | ||
| Q3 25 | 53.5% | 76.6% | ||
| Q2 25 | 67.6% | 76.4% | ||
| Q1 25 | 62.0% | 75.7% | ||
| Q4 24 | 40.0% | 74.9% | ||
| Q3 24 | 43.5% | 77.1% | ||
| Q2 24 | 48.1% | 76.0% | ||
| Q1 24 | 25.6% | 80.0% |
| Q4 25 | -2057.5% | -192.4% | ||
| Q3 25 | -4249.2% | -108.6% | ||
| Q2 25 | -1900.0% | -111.4% | ||
| Q1 25 | -318.0% | -117.9% | ||
| Q4 24 | -2262.9% | -113.5% | ||
| Q3 24 | -11752.2% | -135.5% | ||
| Q2 24 | -4453.8% | -139.2% | ||
| Q1 24 | -5265.3% | -218.6% |
| Q4 25 | -2015.4% | -190.7% | ||
| Q3 25 | -4174.6% | -106.5% | ||
| Q2 25 | -1880.7% | -109.0% | ||
| Q1 25 | -312.0% | -118.2% | ||
| Q4 24 | -2255.1% | -116.8% | ||
| Q3 24 | -11733.0% | -136.3% | ||
| Q2 24 | -4355.8% | -141.6% | ||
| Q1 24 | -5186.9% | -151.7% |
| Q4 25 | $-0.75 | $-0.15 | ||
| Q3 25 | $-0.34 | $-0.10 | ||
| Q2 25 | $-0.30 | $-0.10 | ||
| Q1 25 | $-0.26 | $-0.11 | ||
| Q4 24 | $-2.19 | $0.19 | ||
| Q3 24 | $-0.98 | $-0.35 | ||
| Q2 24 | $-0.36 | $-0.53 | ||
| Q1 24 | $-1.13 | $-0.94 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $11.6M | $3.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-31.5M | $7.3M |
| Total Assets | $25.8M | $10.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.6M | $3.6M | ||
| Q3 25 | $18.7M | $4.5M | ||
| Q2 25 | $24.3M | $8.4M | ||
| Q1 25 | $31.0M | $10.7M | ||
| Q4 24 | $8.6M | $4.9M | ||
| Q3 24 | $3.4M | $1.1M | ||
| Q2 24 | $9.3M | $1.5M | ||
| Q1 24 | $5.6M | $122.0K |
| Q4 25 | $-31.5M | $7.3M | ||
| Q3 25 | $-9.2M | $9.8M | ||
| Q2 25 | $1.1M | $11.6M | ||
| Q1 25 | $10.2M | $13.4M | ||
| Q4 24 | $-12.3M | $6.3M | ||
| Q3 24 | $9.7M | $2.6M | ||
| Q2 24 | $22.7M | $2.9M | ||
| Q1 24 | $11.6M | $-1.2M |
| Q4 25 | $25.8M | $10.4M | ||
| Q3 25 | $43.9M | $13.7M | ||
| Q2 25 | $50.5M | $16.4M | ||
| Q1 25 | $60.4M | $18.0M | ||
| Q4 24 | $35.1M | $11.5M | ||
| Q3 24 | $70.2M | $7.4M | ||
| Q2 24 | $74.7M | $7.5M | ||
| Q1 24 | $71.0M | $5.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.5M | $-531.0K |
| Free Cash FlowOCF − Capex | $-7.0M | $-549.0K |
| FCF MarginFCF / Revenue | -616.7% | -37.1% |
| Capex IntensityCapex / Revenue | 129.9% | 1.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-25.4M | $-7.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.5M | $-531.0K | ||
| Q3 25 | $-4.5M | $-3.0M | ||
| Q2 25 | $-6.3M | $-1.6M | ||
| Q1 25 | $-5.9M | $-1.7M | ||
| Q4 24 | $-5.4M | $-178.0K | ||
| Q3 24 | $-5.5M | $-2.1M | ||
| Q2 24 | $-6.0M | $-2.9M | ||
| Q1 24 | $-3.8M | $-1.1M |
| Q4 25 | $-7.0M | $-549.0K | ||
| Q3 25 | $-5.6M | $-3.0M | ||
| Q2 25 | $-6.6M | $-1.9M | ||
| Q1 25 | $-6.2M | $-2.1M | ||
| Q4 24 | $-5.6M | $-645.0K | ||
| Q3 24 | $-5.6M | $-2.1M | ||
| Q2 24 | $-6.2M | $-3.0M | ||
| Q1 24 | $-3.9M | $-1.2M |
| Q4 25 | -616.7% | -37.1% | ||
| Q3 25 | -2135.4% | -153.2% | ||
| Q2 25 | -1279.5% | -101.1% | ||
| Q1 25 | -288.4% | -117.3% | ||
| Q4 24 | -374.5% | -38.5% | ||
| Q3 24 | -4884.3% | -140.4% | ||
| Q2 24 | -5931.7% | -202.3% | ||
| Q1 24 | -2189.8% | -104.2% |
| Q4 25 | 129.9% | 1.2% | ||
| Q3 25 | 403.8% | 1.7% | ||
| Q2 25 | 67.4% | 17.8% | ||
| Q1 25 | 14.4% | 22.1% | ||
| Q4 24 | 14.4% | 27.9% | ||
| Q3 24 | 75.7% | 2.2% | ||
| Q2 24 | 183.7% | 2.1% | ||
| Q1 24 | 13.6% | 5.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
